These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 10052982
1. Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions. Cervini L, Theobald P, Corrigan A, Craig AG, Rivier C, Vale W, Rivier J. J Med Chem; 1999 Feb 25; 42(4):761-8. PubMed ID: 10052982 [Abstract] [Full Text] [Related]
2. Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges. Rivier J, Lahrichi SL, Gulyas J, Erchegyi J, Koerber SC, Craig AG, Corrigan A, Rivier C, Vale W. J Med Chem; 1998 Jul 02; 41(14):2614-20. PubMed ID: 9651165 [Abstract] [Full Text] [Related]
4. Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat. Rivier J, Gulyas J, Corrigan A, Martinez V, Craig AG, Taché Y, Vale W, Rivier C. J Med Chem; 1998 Dec 03; 41(25):5012-9. PubMed ID: 9836619 [Abstract] [Full Text] [Related]
7. Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat. Rivier JE, Kirby DA, Lahrichi SL, Corrigan A, Vale WW, Rivier CL. J Med Chem; 1999 Aug 12; 42(16):3175-82. PubMed ID: 10447963 [Abstract] [Full Text] [Related]
9. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor. Beyermann M, Fechner K, Furkert J, Krause E, Bienert M. J Med Chem; 1996 Aug 16; 39(17):3324-30. PubMed ID: 8765516 [Abstract] [Full Text] [Related]
10. Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor. Miranda A, Koerber SC, Gulyas J, Lahrichi SL, Craig AG, Corrigan A, Hagler A, Rivier C, Vale W, Rivier J. J Med Chem; 1994 May 13; 37(10):1450-9. PubMed ID: 8182703 [Abstract] [Full Text] [Related]
11. Betidamino acid scan of the GnRH antagonist acyline. Jiang G, Miller C, Koerber SC, Porter J, Craig AG, Bhattacharjee S, Kraft P, Burris TP, Campen CA, Rivier CL, Rivier JE. J Med Chem; 1997 Nov 07; 40(23):3739-48. PubMed ID: 9371239 [Abstract] [Full Text] [Related]
12. Ligand requirements of the human corticotropin-releasing factor-binding protein. Sutton SW, Behan DP, Lahrichi SL, Kaiser R, Corrigan A, Lowry P, Potter E, Perrin MH, Rivier J, Vale WW. Endocrinology; 1995 Mar 07; 136(3):1097-102. PubMed ID: 7867564 [Abstract] [Full Text] [Related]
14. Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides. Mazur AW, Wang F, Tscheiner M, Donnelly E, Isfort RJ. J Med Chem; 2004 Jun 17; 47(13):3450-4. PubMed ID: 15189041 [Abstract] [Full Text] [Related]
15. Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study. Kornreich WD, Galyean R, Hernandez JF, Craig AG, Donaldson CJ, Yamamoto G, Rivier C, Vale W, Rivier J. J Med Chem; 1992 May 15; 35(10):1870-6. PubMed ID: 1316969 [Abstract] [Full Text] [Related]
16. Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicochemical characteristics. Rivier J, Rivier C, Galyean R, Miranda A, Miller C, Craig AG, Yamamoto G, Brown M, Vale W. J Med Chem; 1993 Oct 01; 36(20):2851-9. PubMed ID: 8411000 [Abstract] [Full Text] [Related]
17. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C. Nature; 1995 Nov 16; 378(6554):287-92. PubMed ID: 7477349 [Abstract] [Full Text] [Related]